education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Notritis
Notritis
tenoxicam
Manufacturer:
Caprifarmindo
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Tenoxicam
Indications/Uses
Symptomatic treatment of RA, OA, arthrosis, ankylosing spondylitis, extra-articular disorder eg, tendinitis, bursitis, periarthritis of shoulders, hips, strains & sprains, acute gout.
Dosage/Direction for Use
20 mg once daily.
Gout
40 mg once daily for 2 days then 20 mg once daily for further 5 days.
Administration
Should be taken with food: Take w/ or immediately after meals.
Contraindications
Severe diseases of upper GIT.
Special Precautions
Impaired renal function. Hepatic cirrhosis, CHF, vol depletion. Pregnancy & lactation.
Adverse Reactions
GI upsets, dizziness, headache, rash, erythema, urticaria, decreased Hb, granulocytopenia, mild edema, photodermatosis.
View
ADR Reporting Link
Drug Interactions
K-sparing diuretics.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
ATC Classification
M01AC02 - tenoxicam ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, oxicams.
Regulatory Classification
K
Presentation/Packing
Form
Notritis FC caplet 20 mg
Packing/Price
5 × 10's (Rp200,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk